The Latest News.

- Advertisment -

Lindus Health Obtains Funding to Speed Up Technology Application for Transforming Clinical Trials

- Advertisement -

London-based start-up Lindus Health is using machine learning and data science to revolutionise clinical trials. The company aims to help treatments reach patients more quickly to improve and extend lives. Lindus Health has raised $6m from investors, including Peter Thiel, to accelerate its use of machine learning. The company has also received an Innovate UK Smart Grant worth almost half a million pounds. Lindus Health’s pioneering technology speeds up the time it takes to approve treatments and get them to market, with its trials to date having been completed three times more quickly than the old-fashioned industry standard.

London-based start-up Lindus Health has secured $6 million in funding from investors, including Peter Thiel, to accelerate their use of machine learning and data science to revolutionize clinical trials. The company is developing innovative treatments for conditions such as tinnitus, insomnia, and progressive childhood short-sightedness, using their technology platform and machine learning to manage trials from start to finish in an industry first. Lindus Health aims to help treatments reach patients more quickly to improve and extend lives.

The company has also received an Innovate UK Smart Grant worth almost half a million pounds, with their work in machine learning and data science described by UKRI assessors as a “hugely valuable and game-changing project.” Lindus Health’s pioneering technology speeds up the time it takes to approve treatments and get them to market, with their trials to date having been completed three times more quickly than the old-fashioned industry standard.

- Advertisement -

Lindus Health has already delivered more than 80 trials for treatments across the US, UK, and Europe. They are next working with the global healthcare company Pharmanovia to evaluate the safety and efficacy of a treatment for patients with severe insomnia in a real-world setting. They will also be working with Oto to run a trial for 200 people, evaluating their digital tinnitus solution against in-person therapy. In addition, they are partnering with Berlin-based start-up Dopavision to trial the MyopiaX treatment for children affected by progressive short-sightedness. This aims to increase dopamine levels in the retina to slow the progression of the condition.

Lindus Health is launching a trial aimed at treating and reversing Type 2 Diabetes with George Medicines and a trial aimed at reducing symptoms of menopause, with US-based Bonafide Health (parent company – JDS Therapeutics) this year. Launched in 2021 by Michael Young and Meri Beckwith, Lindus Health has already worked with 20,000 patients to find new treatments for chronic conditions.

Clinical trials are the biggest bottleneck to improving human health. Lindus Health is working to transform the clinical trial process by leveraging machine learning and data science. Their technology platform speeds up the time it takes to approve treatments and get them to market, helping treatments reach patients more quickly. Lindus Health’s work is a game-changer in the industry and has the potential to improve and extend lives.

- Advertisement -

Image Credit: Lindus Health

NewsTechnology NewsLindus Health Obtains Funding to Speed Up Technology Application for Transforming Clinical...
Delia Reynolds
Delia Reynolds
Delia Reynolds is a highly-regarded tech news author with an uncanny ability to captivate readers through engaging, concise, and insightful articles. With a passion for innovation, Delia meticulously dissects the latest developments in technology, leaving no stone unturned in the quest for accurate and comprehensive news coverage.

Disclaimer: We want to be clear that the information on Bollyinside.com, including news, articles, reviews, and opinions, is intended for reading and knowledge purposes only. While we strive to provide accurate and up-to-date information, opinion and news, we cannot guarantee the completeness, accuracy, reliability, suitability, or availability of any information. Read more

Follow us on
Google News
- Advertisment -